Commonwealth Medical Center Llc - Medicare Primary Care in Saipan, MP

Commonwealth Medical Center Llc is a medicare enrolled primary clinic (Clinic/center - Multi-specialty) in Saipan, Northern Mariana Islands. The current practice location for Commonwealth Medical Center Llc is Micro Beach Road, Garapan, Saipan, Northern Mariana Islands. For appointments, you can reach them via phone at (670) 989-2587. The mailing address for Commonwealth Medical Center Llc is Pmb 145 Po Box 10003, Saipan, Northern Mariana Islands and phone number is () -.

Commonwealth Medical Center Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1316646185. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (670) 989-2587.

Contact Information

Commonwealth Medical Center Llc
Micro Beach Road, Garapan
Saipan
MP 96950-0003
(670) 989-2587
Not Available

Primary Care Clinic Profile

Full NameCommonwealth Medical Center Llc
SpecialityClinic/Center
LocationMicro Beach Road, Garapan, Saipan, Northern Mariana Islands
Authorized Official Name and PositionChristine Roque (OFFICE MANAGER)
Authorized Official Contact6709892587
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Commonwealth Medical Center Llc
Pmb 145 Po Box 10003
Saipan
MP 96950

Ph: () -
Commonwealth Medical Center Llc
Micro Beach Road, Garapan
Saipan
MP 96950-0003

Ph: (670) 989-2587

NPI Details:

NPI Number1316646185
Provider Enumeration Date03/01/2023
Last Update Date09/11/2023

Medicare PECOS Information:

Medicare PECOS PAC ID7416312210
Medicare Enrollment IDO20230501001876

News Archive

FDA grants Orphan Drug Designation to Kamada's AAT product for type 1 diabetes

Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

A study led by The University of Texas MD Anderson Cancer Center showed that first-line treatment with a regimen of chemotherapy combined with the monoclonal antibody blinatumomab resulted in increased survival and achieved a high rate of measurable residual disease (MRD) negativity for patients who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative B-cell ALL (Ph-negative B-ALL).

Blood stem cell self-renewal dependent on surroundings

Stem cells have two important capabilities: they can develop into a wide range of cell types and simultaneously renew themselves, creating fresh stem cells. Using a model of the blood forming (hematopoietic) system, researchers at the Technical University of Munich (TUM) have now been able to precisely determine, which signaling pathways play an essential role in the self-renewal of blood stem cells. A particularly decisive role in this process is the interactive communication with surrounding tissue cells in the bone marrow.

Actavis files ANDA to market Budesonide Extended-release Tablets

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Budesonide Extended-release Tablets, 9 mg.

UHCMC improves workflow using Toshiba's suite of systems

One of the top priorities for healthcare facilities today is improving operational efficiency. To help address this issue, University Hospitals Case Medical Center (UHCMC) in Cleveland, Ohio, rated among the best hospitals in the nation, recently purchased a suite of systems from Toshiba America Medical Systems, Inc., including an Aplio MX, two Xario XGs and two Aplio XG systems.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Commonwealth Medical Center Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1316646185NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Secondary
261QM1300XClinic/center - Multi-specialty (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Commonwealth Medical Center Llc acts as a billing entity for following providers:
Provider NameJohn L Doyle
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1295964468
PECOS PAC ID: 1052224508
Enrollment ID: I20190923001832

News Archive

FDA grants Orphan Drug Designation to Kamada's AAT product for type 1 diabetes

Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

A study led by The University of Texas MD Anderson Cancer Center showed that first-line treatment with a regimen of chemotherapy combined with the monoclonal antibody blinatumomab resulted in increased survival and achieved a high rate of measurable residual disease (MRD) negativity for patients who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative B-cell ALL (Ph-negative B-ALL).

Blood stem cell self-renewal dependent on surroundings

Stem cells have two important capabilities: they can develop into a wide range of cell types and simultaneously renew themselves, creating fresh stem cells. Using a model of the blood forming (hematopoietic) system, researchers at the Technical University of Munich (TUM) have now been able to precisely determine, which signaling pathways play an essential role in the self-renewal of blood stem cells. A particularly decisive role in this process is the interactive communication with surrounding tissue cells in the bone marrow.

Actavis files ANDA to market Budesonide Extended-release Tablets

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Budesonide Extended-release Tablets, 9 mg.

UHCMC improves workflow using Toshiba's suite of systems

One of the top priorities for healthcare facilities today is improving operational efficiency. To help address this issue, University Hospitals Case Medical Center (UHCMC) in Cleveland, Ohio, rated among the best hospitals in the nation, recently purchased a suite of systems from Toshiba America Medical Systems, Inc., including an Aplio MX, two Xario XGs and two Aplio XG systems.

Read more Medical News

› Verified 2 days ago

Provider NameTiffany L Willis
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1750370383
PECOS PAC ID: 6406862572
Enrollment ID: I20200316002037

News Archive

FDA grants Orphan Drug Designation to Kamada's AAT product for type 1 diabetes

Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

A study led by The University of Texas MD Anderson Cancer Center showed that first-line treatment with a regimen of chemotherapy combined with the monoclonal antibody blinatumomab resulted in increased survival and achieved a high rate of measurable residual disease (MRD) negativity for patients who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative B-cell ALL (Ph-negative B-ALL).

Blood stem cell self-renewal dependent on surroundings

Stem cells have two important capabilities: they can develop into a wide range of cell types and simultaneously renew themselves, creating fresh stem cells. Using a model of the blood forming (hematopoietic) system, researchers at the Technical University of Munich (TUM) have now been able to precisely determine, which signaling pathways play an essential role in the self-renewal of blood stem cells. A particularly decisive role in this process is the interactive communication with surrounding tissue cells in the bone marrow.

Actavis files ANDA to market Budesonide Extended-release Tablets

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Budesonide Extended-release Tablets, 9 mg.

UHCMC improves workflow using Toshiba's suite of systems

One of the top priorities for healthcare facilities today is improving operational efficiency. To help address this issue, University Hospitals Case Medical Center (UHCMC) in Cleveland, Ohio, rated among the best hospitals in the nation, recently purchased a suite of systems from Toshiba America Medical Systems, Inc., including an Aplio MX, two Xario XGs and two Aplio XG systems.

Read more Medical News

› Verified 2 days ago

News Archive

FDA grants Orphan Drug Designation to Kamada's AAT product for type 1 diabetes

Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

A study led by The University of Texas MD Anderson Cancer Center showed that first-line treatment with a regimen of chemotherapy combined with the monoclonal antibody blinatumomab resulted in increased survival and achieved a high rate of measurable residual disease (MRD) negativity for patients who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative B-cell ALL (Ph-negative B-ALL).

Blood stem cell self-renewal dependent on surroundings

Stem cells have two important capabilities: they can develop into a wide range of cell types and simultaneously renew themselves, creating fresh stem cells. Using a model of the blood forming (hematopoietic) system, researchers at the Technical University of Munich (TUM) have now been able to precisely determine, which signaling pathways play an essential role in the self-renewal of blood stem cells. A particularly decisive role in this process is the interactive communication with surrounding tissue cells in the bone marrow.

Actavis files ANDA to market Budesonide Extended-release Tablets

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Budesonide Extended-release Tablets, 9 mg.

UHCMC improves workflow using Toshiba's suite of systems

One of the top priorities for healthcare facilities today is improving operational efficiency. To help address this issue, University Hospitals Case Medical Center (UHCMC) in Cleveland, Ohio, rated among the best hospitals in the nation, recently purchased a suite of systems from Toshiba America Medical Systems, Inc., including an Aplio MX, two Xario XGs and two Aplio XG systems.

Read more News

› Verified 2 days ago


Clinic/Center in Saipan, MP

Kaiser Group Of Medical Clinics & Residential Facilities, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: Nauru Loop St, Marianas Business Plaza, 4th Floor, Rm 402, Saipan, MP 96950
Phone: 670-234-8005    Fax: 670-234-8028
Medical Associates Of The Pacific Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: Marina Heights Business Park, Suite 100, Saipan, MP 96950
Phone: 670-323-9000    Fax: 670-323-9010
Kagman Community Health Center, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 856 Chalan Tun Thomas P. Sablan San Antonio, Saipan, MP 96950
Phone: 670-256-5242    Fax: 670-256-5244
Marianas Dental Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: Tsl Plaza 2nd Floor Beach Road, Saipan, MP 96950
Phone: 670-234-3810    Fax: 670-234-3820
Mmc & Pacific Labs, Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: Jkr Building Beach Road Garapan, Saipan, MP 96950
Phone: 670-285-1401    Fax: 670-234-3926
Modern Solutions
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1 Dahon Drive, Unit# Wc-3, Saipan, MP 96950
Phone: 670-234-5302    Fax: 670-234-5303

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.